Skip to main content
. 2020 Oct 28;9(11):3479. doi: 10.3390/jcm9113479

Figure 1.

Figure 1

Receiver operating characteristic (ROC) analysis. Time (in months) from CNI-based to belatacept-based therapy regarding the occurrence of opportunistic infections. ROC analysis: area under the curve (AUC) value = 0.69, specificity 70.6%, sensibility 64.3% for a time to conversion at 8 months after kidney transplantation.